Successful Live Case Demonstration Of Elixir Medical’s CE Mark-Approved Fully Bioresorbable DESolve® 100 Novolimus Eluting Coronary Scaffold System At EuroPCR

Elixir Medical Corporation, a developer of products that combine state-of-the-art medical devices with advanced pharmaceuticals, announced today that the successful live case demonstration of its breakthrough DESolve® 100 Novolimus Eluting Bioresorbable Coronary Scaffold System was presented at the “Multivessel PCI: Whats’s new?” session at EuroPCR in Paris. EuroPCR is the official annual meeting of the European Association for Percutaneous Cardiovascular Interventions.

Help employers find you! Check out all the jobs and post your resume.